http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GR-1004331-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b552f0232ce3722079645316e7f1fc87 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-663 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate | 2002-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a35bcdea828ff9d1d0c49efe6c2227a |
| publicationDate | 2003-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GR-1004331-B |
| titleOfInvention | NEW PHARMACEUTICAL COMPOSITIONS CONTAINING ALENDRONIC ACID |
| abstract | the pharmaceutical compositions containing Alendronic acid as an active ingredient in the form of its salts in aqueous form in a specific combination with excipients and the use of mannitol as a diluent. The said pharmaceutical compositions will be prepared in a new way of production using new carriers. The pharmaceutical forms described are capsules, tablets as well as granules or powders for the preparation of drinkable suspensions in various strengths.nSaid pharmaceutical forms are prepared by liquid granulation of the mixture of excipients using water.nThe above pharmaceutical compositions are used to combat and prevent osteoporosis. H |
| priorityDate | 2002-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.